EP. 13 Providing Support for Comorbidities and Psychological Health in Patients with Atopic Dermatitis
Case 1: Choosing Non-Steroidal Topicals for Intertriginous PsoriasisByTina Bhutani-Jacques, MDJuly 20th 2026
The Ongoing Role of Topical Therapy in Plaque Psoriasis ManagementByTina Bhutani-Jacques, MDJuly 20th 2026
ED Treatment Gaps Persist for Pediatric Atopic DermatitisByChristopher G. Bunick, MD, PhD,Shannon Heaning, Content AssociateJuly 18th 2026
Precision Medicine in Atopic Dermatitis: Current Challenges and Future DirectionsByChristopher G. Bunick, MD, PhD,Shannon Heaning, Content AssociateJuly 15th 2026
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe ADByMarie Bosslett, Assistant EditorJuly 15th 2026